Ocular histoplasmosis is a fungal infection that affects the eyes. It is caused by the fungus Histoplasma capsulatum, which is found in soil and bird droppings. Ocular histoplasmosis is a relatively rare condition, but it can cause significant vision loss if left untreated. In this article, we will take a closer look at the causes and treatment options for ocular histoplasmosis.
Ocular histoplasmosis (OH) is an infection of the eyes caused by the fungus Histoplasma capsulatum. The fungus is found in soil and bird droppings, and it is most commonly found in the Mississippi and Ohio River valleys. OH is a relatively rare condition, but it can cause significant vision loss if left untreated. OH is typically spread through airborne spores, which can be inhaled and then deposited in the lungs. The fungus can then spread to the eyes, where it can cause inflammation and damage to the retina and other parts of the eye. Symptoms of OH include blurred vision, floaters, and sensitivity to light. In some cases, OH can cause scarring of the retina, which can lead to permanent vision loss.
The primary cause of OH is exposure to the fungus Histoplasma capsulatum. This fungus is found in soil and bird droppings, and it is most commonly found in the Mississippi and Ohio River valleys. The fungus is spread through airborne spores, which can be inhaled and then deposited in the lungs. The fungus can then spread to the eyes, where it can cause inflammation and damage to the retina and other parts of the eye.
There are several factors that can increase the risk of developing OH. These include: • Living in or traveling to an area where the fungus is common • Exposure to bird droppings • Working in a profession that involves frequent exposure to soil or bird droppings • Having a weakened immune system
OH is typically diagnosed through a physical examination and a series of tests. The doctor may use a slit-lamp examination to look for signs of inflammation in the eyes. The doctor may also order a chest x-ray to check for signs of the fungus in the lungs. In some cases, a sample of fluid may be taken from the eye and examined under a microscope for signs of the fungus.
The primary treatment for OH is antifungal medication. The medication is typically taken orally for several weeks, and it can help to reduce the inflammation and clear up the infection. In some cases, a steroid may be prescribed to reduce inflammation in the eye. In severe cases of OH, surgery may be necessary to remove scar tissue from the retina. This can help to improve vision and prevent further damage. In some cases, laser treatment may be used to reduce the risk of vision loss.
Ocular histoplasmosis is a fungal infection of the eyes that can cause significant vision loss if left untreated. The primary cause of OH is exposure to the fungus Histoplasma capsulatum, which is found in soil and bird droppings. Risk factors for OH include living in or traveling to an area where the fungus is common, exposure to bird droppings, and having a weakened immune system. Treatment typically involves antifungal medication, and in some cases, surgery may be necessary to improve vision.
1.
It Is Not Just the Royals Who Go Through Cancer.
2.
Have the Harms of Lung Cancer Screening Been Exaggerated?
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
Novel Agent for Chronic GVHD Wins FDA Approval
5.
Rising rates of head and neck cancers in England
1.
Targeted Therapy: Latest Advances, Learning Tools, Trials & Treatment Options Explained
2.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
3.
Understanding the Causes and Symptoms of Cavernous Sinus Thrombosis
4.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
5.
Revolutionizing Cancer Care: The Impact of Darzalex Faspro
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Hematology
2.
From Guidelines to Practice: Hematology
3.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation